Search Results 191-200 of 16405 for infliximab

  1. Examining the clinical presentation and imaging characteristics of cryptogenic multifocal ulcerous stenosing enteritis

    ... infliximab. Recurrence to medical therapy (median of four months after treatment) occurred in six (85.7%) patients. Surgery for refractory intestinal ...

  2. Rituximab-pvvr (intravenous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Rotavirus Vaccine, Live; SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine ...

  3. Etanercept-ykro (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Cholera Vaccine, Live; Cyclophosphamide; Dengue Tetravalent Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live ...

  4. Baricitinib (oral route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Ixekizumab; Leflunomide; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Nitisinone; Poliovirus Vaccine, Live ...

  5. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept within 2 weeks; infliximab, certolizumab, golimumab, or adalimumab within 8 weeks) prior to ...

  6. Obiltoxaximab (intravenous route) - Side effects & uses - Mayo Clinic

    Obiltoxaximab injection is used together with antibiotics to treat inhalational anthrax. It is also used to prevent inhalational anthrax after a person is ...

  7. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and ...

  8. Ustekinumab-auub (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  9. Impact Of Surgical Removal Or Reduction Procedures On Markers Of Immune Function In Adult Patients With Renal And Bladder Tumors And Pediatric Patients With Genitourinary Tumors - Mayo Clinic

    infliximab), chemotherapy) or imunosuppressive condition (ex. transplant, immunodeficiency syndromes, HIV/AIDS); Auto-immune disease (ex. lupus, rheumatoid ...

  10. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    Infliximab, certolizumab, golimumab, ABA or adalimumab within ≤ 8 weeks; Anakinra within ≤ 1 week. Pulmonary disease with FVC ≤ 50% of predicted, or DLCO ...